Venmax Drugs & Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 1.36 | 0.20 | 0.17 |
| Operating Expense | 0.58 | 0.69 | 0.47 |
| Net Profit | 0.78 | -0.50 | -0.30 |
| Net Profit Margin | 57.35 | -250 | -176.47 |
| Earning Per Share | 1.49 | -0.95 | -0.58 |
| EBIDTA | 0.78 | -0.50 | -0.30 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 1.36 |
| Operating Expense | 0.58 |
| Net Profit | 0.78 |
| Net Profit Margin | 57.35 |
| Earning Per Share | 1.49 |
| EBIDTA | 0.78 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | TBA | TBA | TBA |
| Operating Expenses Annual | 0.10 | 0.19 | 0.13 |
| Operating Profit Annual | 0.09 | 0.23 | 1.86 |
| Interest Annual | TBA | TBA | TBA |
| Depreciation | TBA | TBA | 0.01 |
| Net Profit Annual | 0.06 | 0.23 | 1.85 |
| Tax Annual | 0.02 | 0.00 | 0.00 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | TBA |
| Operating Expenses Annual | 0.10 |
| Operating Profit Annual | 0.09 |
| Interest Annual | TBA |
| Depreciation | TBA |
| Net Profit Annual | 0.06 |
| Tax Annual | 0.02 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | TBA | TBA | 0.08 |
| Cash Flow from Operations | TBA | TBA | 1.91 |
| Cash Flow from Investing | TBA | TBA | TBA |
| Cash Flow from Financing | TBA | TBA | -1.98 |
| Cash Flow at the End | TBA | TBA | TBA |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | TBA |
| Cash Flow from Operations | TBA |
| Cash Flow from Investing | TBA |
| Cash Flow from Financing | TBA |
| Cash Flow at the End | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | TBA | TBA | TBA |
| PBIT Margin (%) | TBA | TBA | TBA |
| PBT Margin (%) | TBA | TBA | TBA |
| Net PROFIT Margin (%) | TBA | TBA | TBA |
| Return On Networth / Equity (%) | 1.15 | 4.10 | 116.35 |
| Return On Networth /Employed (%) | 1.43 | 3.86 | 63.14 |
| Return On Assets (%) | TBA | TBA | TBA |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | TBA | TBA | TBA |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | TBA |
| PBIT Margin (%) | TBA |
| PBT Margin (%) | TBA |
| Net PROFIT Margin (%) | TBA |
| Return On Networth / Equity (%) | 1.15 |
| Return On Networth /Employed (%) | 1.43 |
| Return On Assets (%) | TBA |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 0.07 | 0.07 | 0.08 |
| Total Current Assets Annual | 0.02 | 0.14 | 0.13 |
| Non Current Assets Annual | 0.07 | 0.07 | 0.08 |
| Total Shareholders Funds Annual | -0.65 | -0.71 | -0.94 |
| Total Assets Annual | 0.08 | 0.21 | 0.21 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 0.07 |
| Total Current Assets Annual | 0.02 |
| Non Current Assets Annual | 0.07 |
| Total Shareholders Funds Annual | -0.65 |
| Total Assets Annual | 0.08 |
No Data Availabe
